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We studied the effects of insulin on the incorporation of 32P i into phospholipids in rat fat cells. When the 
cells were treated with insulin, a new radioactive phospholipid was detected on thin layer chromatography. 
The substance migrated slower than phosphatidylinositol 4,5-bisphosphate nd was hardly detectable in the 
absence of insulin. This effect of insulin was both time- and dose-dependent wi h half-maximal stimulation 
at 120 #U/ml. Pretreatment of insulin with anti-insulin antibody or the cells with anti-insulin receptor anti- 
body inhibited the effect of insulin. The product of phosphatidylinositol 4-phosphate hydrolyzed by phos- 
pholipase Az was coincided with the substance on thin layer chromatography. Quinacrine inhibited the for- 
mation of the substance in a dose-dependent manner. These results suggested that insulin stimulates the 
generation of lysophosphatidylinositol 4-phosphate hrough the insulin-receptor interaction. 
Insulin; Phosphoinositide; Phospholipase Az; (Rat fat cell) 
1. INTRODUCTION 
Since the early observation that insulin 
stimulates the incorporation of [32p]Pi into 
phospholipids in fat tissue was reported [1], many 
studies have been reported about the effects of in- 
sulin on phosphoinositide metabolism [2-4]. Pen- 
nington et al. [5] reported that insulin stimulated 
the de novo synthesis of phosphoinositide, but had 
no effects on phosphoinositide breakdown in fat 
cells. Recently, Farese et al. [6] demonstrated that 
insulin had the effects in rat fat tissue of a transient 
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activation of phospholipase C and a persistent in- 
crease in de novo phospholipid synthesis. 
The actions of insulin are thought to be pro- 
duced by the interaction of insulin with its recep- 
tors on the plasma membranes. It has been 
suggested that one or more chemical mediators are 
generated subsequent to this interaction and alter 
the activities of some insulin sensitive enzymes 
[7,8]. Several investigators suggest he possibility 
that insulin generated chemical mediators by ac- 
tivating an insulin-sensitive phospholipase C acting 
as a novel glycophospholipid [9-11]. 
In the course of our studies of the actions of in- 
sulin on phospholipid metabolism, a radioactive 
substance migrating slower than phosphatidyl- 
inositol 4,5-bisphosphate on thin layer chroma- 
tography (TLC) was detected in the phospholipid 
fraction of rat fat cells incubated with [32p]Pi in 
the presence of insulin. The examination of 
characteristics of this substance indicated that it 
might be lysophosphatidylinositol 4-phosphate. 
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2. EXPERIMENTAL 
2.1. Preparation o f fat cells 
Fat cells were isolated by the method of Rodbell 
[12] with the following minor modifications. 
Epididymal fat pads (1 g/ml) from male Sprague- 
Dawley rats (140-180 g) were incubated with col- 
lagenase (3.5 mg/ml, Cooper Biomedical) for 
45 min at 37°C. The incubation medium used 
throughout preparation was a modified Krebs- 
Ringer bicarbonate buffer, pH 7.4 (KRBB, 
0.154 M NaC1, 0.154M KC1, 0.055 M CaCI2, 
0.154 M KHzPO4, 0.154 M MgSO4 and 1.3% 
NaHCO3) supplemented with 2% bovine serum 
albumin (w/v) gassed with O2/CO2 (19: 1). The 
digested fat pad was then filtered through a nylon 
mesh with 15 ml of KRBB buffer. After washing 
with KRBB buffer containing 10 mM glucose, 
isolated fat cells were preincubated for 20 min with 
the same buffer. 
2.3. Phospholipase A2 treatment 
Phospholipase A2 (from Naja naja venom, 
Sigma) in 0.1 M borate buffer, pH 8.9, containing 
20 mM calcium acetate (100 U/ml) was added to a 
lipid extract suspended in ether/methanol (98:2, 
v/v) and then the mixture was incubated for 2 h at 
room temperature [14]. The reaction was stopped 
by the addition of chloroform/methanol/12 N 
HC1 (200: 100:0.75, v/v). 
2.4. Other methods 
Protein was determined by the method of Lowry 
et al. [15]. Deacylation was based on the method of 
Creba et al. [16]. Anti-insulin IgG was prepared 
from guinea pig anti-insulin serum by ammonium 
sulfate precipitation and DEAE-cellulose column 
chromatography [17]. Control IgG was prepared 
from non-immunized guinea pig serum. Anti- 
insulin receptor serum (B5) was a kind gift from Dr 
Kasuga of Tokyo University. 
2.2. Measurement of phosphoinositide 
metabolism 
Fat cells (4 x 105 cells/ml) were usually in- 
cubated with [32p]Pi (25-40/~Ci/ml, New England 
Nuclear) at 37°C for various times with or without 
insulin. The reaction was terminated by the addi- 
tion of 2.5 ml of ice cold chloroform/methanol/  
12 N HC1 (100: 100:0.75, v/v) to 0.5 ml of incuba- 
tion mixture [13]. The mixture was allowed to 
stand for 10 min at 0°C and then 0.5 ml of 0.6 N 
HC1 was added. After centrifugation, the upper 
phase was removed and the lower phase was wash- 
ed twice with 1 ml of chloroform/methanol/0.6 N 
HC1 (3:48:47, v/v). An aliquot (0.25 ml) of the 
lower phase was dried under a stream of nitrogen. 
TLC was performed by the method of Jolles [13] 
using silica gel G plate (Merck). Before use, the 
plates were developed in methanol/water (2:3, 
v/v) containing I% potassium oxalate and ac- 
tivated at l l0°C for 30 min. The lipid extracts 
were applied to the plates and developed with 
chloroform/acetone/methanol/acetic acid/water 
(40: 15: 13: 12:8, v/v). Lipids were visualized by 
iodine staining and radiolabelled spots were 
detected by autoradiography on Fuji X-ray film. 
The radioactive spots were scraped from the plate 
and counted in a liquid scintillation spec- 
trophotometer. 
3. RESULTS AND DISCUSSION 
3.1. Effect of insulin on the incorporation of 
[32P]Pi into phospholipids 
Insulin caused an increase of the incorporation 
of [32p]Pi into total and each phospholipid frac- 
tion (i.e. PS + PC, PI, PIP, PIP2) of rat fat ceils. 
These effects of insulin agreed with the result of 
Farese et al. [6]. In addition, a substance which 
migrated slightly slower than PIP2 on TLC, was 
detected as shown in fig.1. 
Fig.2A shows that the incorporation of [32p]Pi 
into the substance was enhanced by insulin in a 
dose-dependent manner. The half-maximal activa- 
tion was approx. 120/~U/ml of insulin. 
Fig.2B shows the results of time course ex- 
periments in the presence or absence of insulin 
(1 mU/ml). The rate of increase of [32p]Pi incor- 
poration into the substance by insulin was much 
higher than that into PI, PIP and PIP2 (not 
shown). 
After incubation of fat cells with [32p]Pi and in- 
sulin for 30 min in phosphate-free buffer, [32p]Pi 
was removed from the medium by repeated 
washing with KRBB buffer and the incubation was 
continued in the presence of insulin. The radioac- 
tivity of the substance became hardly detectable 
within 30 min (not shown). The results of these ex- 
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Fig. 1. Separations of [32p]Pi-labelled phospholipids in
rat fat cells. Fat cells were incubated with [32p]Pi 
(25/~Ci/ml) in the presence of insulin at the indicated 
concentrations for 60min at 37°C. Samples were 
extracted and separated by TLC. Radioactive spots were 
located by autoradiography. 
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Fig.2. Effect of insulin on the incorporation of [32p]Pi 
into the substance in rat fat cells. (A) Fat cells were 
incubated with [32p]Pi (40/~Ci/ml) and insulin 
(0-1000/~U/ml) for 60 rain in phosphate-free KRBB. 
After extraction and separation on TLC, the radioactive 
spot was scraped and counted. (B) Fat cells were 
incubated with [3Zp]Pi (25/~Ci/ml) in the presence 
( ) or absence ( - - - )  of insulin (1 mU/ml). Samples 
were removed at the times indicated and lipids were 
extracted as described in section 2. Data are expressed as 
the mean + SD of triplicate determinations. Similar 
results were obtained with 3 separate fat cell 
preparations. 
periments indicate the substance to be 
metabolized. 
3.2. Effect of anti-insulin antibody and anti- 
insulin receptor antibody 
When fat cells were incubated with insulin in the 
presence of anti-insulin antibody, or anti-insulin 
receptor antibody, the effect of insulin on the in- 
corporation of [3Zp]Pi into the substance decreased 
to 19O7o and 37%, respectively (table 1). These 
results suggest that the activation of the incorpora- 
tion of [3ZP]Pi into the substance is due to the ac- 
tion of insulin through the insulin receptor. 
3.3. Characteristics of the substance 
The substance had the following characteristics: 
(i) the ratio of the radioactivity of PIP2/substance 
on TLC was not changed by repeated washing (2-5 
times) with methanol/1.2 N HC1 (1:1, v/v). (ii) 
The radioactivity of the substance was recovered in 
the water phase after deacylation with mild alkali. 
(iii) When extracted lipids were applied to a silicic 
acid column following the method of Rouser et al. 
[18], the radioactivity of the substance was eluted 
with methanol, but not with chloroform. These 
characteristics uggest that the substance is a 
phospholipid. 
When fat cells were incubated with D-myo- 
[3H]inositol (New England Nuclear) in the 
presence of insulin for 2 h, no significant incor- 
poration of [3H]inositol into the substance was 
observed in spite of good incorporation of that in- 
to the PI. It might be due to a much smaller 
amount of radioactivity coming from [3H]inositol- 
labelled PI to the substance for this incubation 
time. 
Fat cells were incubated with insulin in the 
presence of quinacrine (0-1 mM), an inhibitor of 
phospholipase A2. The radioactivity of substance 
was reduced in a dose-dependent manner (table 2). 
This result suggests that the substance is 
lysophospholipid. 
To determine the possibility as mentioned 
above, we examined the effect of phospholipase A2 
treatment, on labelled phospholipids that were ex- 
tracted from fat cells (fig.3). The autoradiogram 
shows that the radioactivity of phospholipid 
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Table 1 
Effects of anti-insulin antibody and anti-insulin receptor 
antibody on the incorporation of [32p]Pi into the 
substance in rat fat ceils 
,e-front 
Treatments Incorporation of 
[32P]P i
(cpm × 10-3/100 mg 
protein) 
Anti-insulin antibody ( - )  
Anti-insulin antibody (+)a 
Anti-insulin receptor 
antibody ( - )b 
Anti-insulin receptor 
antibody ( + ) 
4.84 _ 0.25 
0.92 _+ 0.06 
4.59 _+ 0.26 
1.71 + 0.18 
a After insulin was incubated with or without anti- 
insulin antibody in KRBB buffer containing 10 mM 
glucose for 60 rain at room temperature, fat cells and 
[32p]Pi (25/~Ci/ml) were added to the medium. The 
incubations were continued for 30 rain at 37°C 
b Fat cells were preincubated for 30 min with or without 
anti-insulin receptor antibody, and then incubated 
with [32p]Pi (25/zCi/ml) in the presence of insulin 
(1 mU/ml) for 30 rain at 37°C. Phospholipids were 
extracted and separated by TLC as described in section 
2. Each value is mean + SD of 4 determinations 
"~-- PC, PS 
~-- PI 
Q ~ PIP 
~--P IP2  
,-- origin 
a b c 
products hydrolyzed by the enzyme increased in 
the area corresponding to the substance, which 
coincided with the product  of  labelled P IP  treated 
with the enzyme on TLC.  This suggests that the 
substance is the lyso form of  P IP .  
Table 2 
Effect of quinacrine on the incorporation of [32p]Pi into 
the substance in rat fat cells treated with insulin 
Fig.3. Autoradiograms of phospholipids treated with 
phospholipase A2. (a) Fat cells were incubated with 
[3Zp]Pi (25/~Ci/ml) in the presence of insulin 
(1 mU/ml). (b) Fat cells were incubated with [32p]Pi in 
the absence of insulin. Extracted lipids were treated with 
phospholipase A2. The treatment of phospholipase A2 is 
described in section 2. (c) Fat cells were labelled with 
[32p]Pi. Labelled PIP purified by TLC was treated with 
phospholipase A2. 
Quinacrine (raM) Incorporation of [32p]Pi 
(cpm × 10-3/100 mg 
protein) 
0 2.56 _+ 0.14 
0.1 1.81 + 0.19 
0.5 1.07 _+ 0.08 
1.0 0.59 _+ 0.09 
Fat cells were preincubated with [32p]Pi (25/zCi/ml) for 
30 min. Then the cells were treated with insulin 
(1 mU/ml) in the presence of quinacrine (0-1 raM) for 
15 rain. Lipids were extracted and separated by TLC as 
described in section 2. Each value is mean _+ SD of 4 
determinations 
I f  insulin stimulates phosphol ipase A2, other 
lysophosphol ip ids should be increased with in- 
sulin. We examined the effect of insulin using 
another  basic solvent system (ch lo ro form/metha-  
no l /NH4OH/water ,  90: 70: 11 ." 1 l,  v/v).  The in- 
corporat ion of  [32p]Pi into other lysophos- 
phol ip ids was not effected by insulin. Therefore,  
insulin presumably stimulates only the phos- 
phol ipase A2 acting on P IP .  
Gumber  et al. [19] reported that a product  
formed from P IP  in the presence of  bivalent metal 
ions and ATP  showed an Rf value very close to that 
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of PIP2 on TLC with an acidic solvent and that the 
product was phosphatidylinositol 4-pyrophos- 
phate. The possibility that the substance observed 
under our labelling conditions is phosphatidylino- 
sitol 4-pyrophosphate was excluded from the find- 
ing that hydrolysis of the substance in 0.05 M 
H2SO4 at 100°C for 7 min resulted in no release of 
radioactivity as orthophosphate. 
Batty et al. [20] showed that inositol 
1,3,4,5-tetraphosphate ccumulates in rat brain 
stimulated with carbachol. But there is no proof of 
the existence of a parent lipid from which this may 
be derived (i.e. phosphatidylinositol riphosphate). 
This question has yet to be clarified. 
Saltiel et al. [9,10] and Mato et al. [11] 
demonstrated the possibility that insulin generated 
chemical mediators by activating an insulin- 
sensitive phospholipase C acting on a novel 
glycophospholipid. Although this glycolipid 
migrated between PIP and PI, our undefined 
phospholipid migrated slower than PIP2 by the 
similar solvent system on TLC. 
Further examination is needed for the deter- 
mination of the chemical identity and physiologi- 
cal significance of this phospholipid. 
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